Radiation leukemogenesis in mice: Loss of pu.1 on chromosome 2 in CBA and C57BL/6 mice after irradiation with 1 GeV/nucleon 56Fe Ions, X Rays or γ Rays. Part I. Experimental observations

Radiation Research

Volumn 171, Issue 4, 2009, Pages 474-483

  Peng, Yuanlin ^a   Brown, Natalie ^b   Finnon, Rosemary ^b   Warner, Christy L ^a   Liu, Xianan ^a   Genik, Paula C ^a   Callan, Matthew A ^a   Ray, F Andrew ^a   Borak, Thomas B ^a   Badie, Christophe ^b   Bouffler, Simon D ^b   Ullrich, Robert L ^a   Bedford, Joel S ^a   Weil, Michael M ^a  

^a Department of Environmental and Radiological Health Sciences   (United States)

^b PUBLIC HEALTH ENGLAND   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

IRON; TRANSCRIPTION FACTOR PU 1; ONCOPROTEIN; PROTO ONCOGENE PROTEIN SPI 1; PROTO-ONCOGENE PROTEIN SPI-1; TRANSACTIVATOR PROTEIN;

ACUTE GRANULOCYTIC LEUKEMIA; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BONE MARROW CELL; C57BL 6 MOUSE; CANCER MODEL; CBA MOUSE; CHROMOSOME 2; GAMMA RADIATION; GENE DELETION; IRRADIATION; MALE; MITOSIS; MOUSE; MOUSE STRAIN; NONHUMAN; NUCLEON; PRIORITY JOURNAL; RADIATION DOSE; X RAY; ANIMAL; BACTERIAL ARTIFICIAL CHROMOSOME; C57BL MOUSE; CHROMOSOME; GENE EXPRESSION REGULATION; LEUKEMIA; METABOLISM; RADIATION INJURY; RADIATION RESPONSE;

MUS;

ANIMALS; CHROMOSOMES; CHROMOSOMES, ARTIFICIAL, BACTERIAL; DOSE-RESPONSE RELATIONSHIP, RADIATION; GAMMA RAYS; GENE EXPRESSION REGULATION, LEUKEMIC; IRON; LEUKEMIA; MALE; MICE; MICE, INBRED C57BL; MICE, INBRED CBA; NEOPLASMS, RADIATION-INDUCED; PROTO-ONCOGENE PROTEINS; TRANS-ACTIVATORS; X-RAYS;

EID: 66149141471     PISSN: 00337587     EISSN: None     Source Type: Journal    
DOI: 10.1667/RR1547.1     Document Type: Article

References (25)

1. NCRP, Limitation of Exposure to Ionizing Radiation. Report No. 116, National Council on Radiation Protection and Measurements, Bethesda, MD, 1993.
2. NCRP, Radiation Protection Guidance for Activities in Low-Earth Orbit. Report No. 132, National Council on Radiation Protection and Measurements, Bethesda, MD, 2000.
3. ICRP, Recommendations of the International Commission on Radiological Protection. Publication 26, Annals of the ICRP, Vol. 1, Elsevier Science, New York, 1977.
4. ICRP, 1990 Recommendations of the International Commission on Radiological Protection. Publication 60, Annals of the ICRP, Vol. 21, Elsevier Science, New York, 1991.
5. F. Darakhshan, C. Badie, J. Moody, M. Coster, R. Finnon, P. Finnon, A. A. Edwards, M. Szluinska, C. J. Skidmore and S. D. Bouffler, Evidence for complex multigenic inheritance of radiation AML susceptibility in mice revealed using a surrogate phenotypic assay. Carcinogenesis 27, 311-318 (2006).
6. S. Bouffler, A. Silver, D. Papworth, J. Coates and R. Cox, Murine radiation myeloid leukemogenesis - relationship between interstitial telomere-like sequences and chromosome 2 fragile sites. Genes Chromosomes Cancer 6, 98-106 (1993).
7. A. Silver, S. Bouffler, P. Finnon, E. Rance, D. Morris and R. Cox, Site-specific chromosome-damage and myeloid leukemogenesis in the CBA mouse. Radiat. Prot. Dosimetry 52, 461-464 (1994).
8. S. D. Bouffler, E. I. M. Meijne, R. Huiskamp and R. Cox, Chromosomal abnormalities in neutron-induced acute myeloid leukemias in CBA/H mice. Radiat. Res. 146, 349-352 (1996).
9. S. D. Bouffler, G. Breckon and R. Cox, Chromosomal mechanisms in murine radiation acute myeloid leukaemogenesis. Carcinogenesis 17, 655-659 (1996).
10. S. D. Bouffler, E. I. M. Meijne, D. J. Morris and D. Papworth, Chromosome 2 hypersensitivity and clonal development in murine radiation acute myeloid leukaemia. Int. J. Radiat. Biol. 72, 181-189 (1997).
11. A. Silver, J. Moody, R. Dunford, D. Clark, S. Ganz, R. Bulman, S. Bouffler, P. Finnon, E. Meijne and R. Cox, Molecular mapping of chromosome 2 deletions in murine radiation-induced AML localizes a putative tumor suppressor gene to a 1.0 cM region homologous to human chromosome segment 11p11-12. Genes Chromosomes Cancer 24, 95-104 (1999).
12. P. Finnon, H. P. Wong, A. R. J. Silver, P. Slijepcevic and S. D. Bouffler, Long but dysfunctional telomeres correlate with chromosomal radiosensitivity in a mouse AML cell line. Int. J. Radiat. Biol. 77, 1151-1162 (2001).
13. W. D. Cook, B. J. McCaw, C. Herring, D. L. John, S. J. Foote, S. L. Nutt and J. M. Adams, PU.1 is a suppressor of myeloid leukemia, inactivated in mice by gene deletion and mutation of its DNA binding domain. Blood 104, 3437-3444 (2004).
14. N. Suraweera, E. Meijne, J. Moody, L. G. Carvajal-Carmona, K. Yoshida, P. Pollard, J. Fitzgibbon, A. Riches, T. van Laar and A. Silver, Mutations of the PU.1 Ets domain are specifically associated with murine radiation-induced, but not human therapy-related, acute myeloid leukaemia. Oncogene 24, 3678-3683 (2005).
15. E. Boulton, C. Cole, A. Knight, H. Cleary, R. Snowden and M. Plumb, Low-penetrance genetic susceptibility and resistance loci implicated in the relative risk for radiation-induced acute myeloid leukemia in mice. Blood 101, 2349-2354 (2003).
16. 56Fe ions, X rays or γ rays. Part II. Theoretical considerations based on microdosimetry and the initial induction of chromosome aberrations. Radiat. Res. 171, 484-493 (2009).
17. R. H. Mole, D. G. Papworth and M. J. Corp, The dose-response for X-ray induction of myeloid-leukemia in male CBA/H mice. Br. J. Cancer 47, 285-291 (1983).
18. R. L. Ullrich and R. J. Preston, Myeloid leukemia in male RFM mice following irradiation with fission spectrum neutrons or gamma rays. Radiat. Res. 109, 165-170 (1987).
19. E. I. M. Meijne, A. R. J. Silver, S. D. Bouffler, D. J. Morris, E. W. vanKampen, S. Spanjer, R. Huiskamp and R. Cox, Role of telomeric sequences in murine radiation-induced myeloid leukaemia. Genes Chromosomes Cancer 16, 230-237 (1996).
20. B. T. Kile, C. L. Mason-Garrison and M. J. Justice, Sex and strain-related differences in the peripheral blood cell values of inbred mouse strains. Mamm. Genome 14, 81-85 (2003).
21. L. L. Peters, E. M. Cheever, H. R. Ellis, P. A. Magnani, K. L. Svenson, R. Von Smith and M. A. Bogue, Large-scale, high-throughput screening for coagulation and hematologic phenotypes in mice. Physiol. Genomics 11, 185-193 (2002).
22. V. E. Sollars, E. Pequignot, J. L. Rothstein and A. M. Buchberg, Analysis of expansion of myeloid progenitors in mice to identify leukemic susceptibility genes. Mamm. Genome 17, 808-821 (2006).
23. M. Jawad, C. Cole, A. Zanker, G. Giotopoulos, S. Fitch, C. J. Talbot and M. Plumb, QTL analyses of lineage-negative mouse bone marrow cells labeled with Sca-1 and c-Kit. Mamm. Genome 19, 190-198 (2008).
24. D. J. Clark, E. I. M. Meijne, S. D. Bouffler, R. Huiskamp, C. J. Skidmore, R. Cox and A. R. J. Silver, Microsatellite analysis of recurrent chromosome 2 deletions in acute myeloid leukaemia induced by radiation in F1 hybrid mice. Genes Chromosomes Cancer 16, 238-246 (1996).
25. C. Wiese, S. S. Gauny, W. C. Liu, C. L. Cherbonnel-Lasserre and A. Kronenberg, Different mechanisms of radiation-induced loss of heterozygosity in two human lymphoid cell lines from a single donor. Cancer Res. 61, 1129-1137 (2001).